1501 related articles for article (PubMed ID: 29786072)
1. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
[TBL] [Abstract][Full Text] [Related]
3. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
[TBL] [Abstract][Full Text] [Related]
5. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
6. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
7. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
8. [Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells].
Huang H; Gao Y; Nie K; Wang L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):972-979. PubMed ID: 34308845
[TBL] [Abstract][Full Text] [Related]
9. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
[TBL] [Abstract][Full Text] [Related]
10. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
[TBL] [Abstract][Full Text] [Related]
12. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
14. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
15. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
[TBL] [Abstract][Full Text] [Related]
17. Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.
Qiao C; Dang T; Zhou Y; Zhou YZ; Zhao R; Wang M
Brain Behav; 2022 Nov; 12(11):e2784. PubMed ID: 36199191
[TBL] [Abstract][Full Text] [Related]
18. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.
Zhou L; Wang X; Wang X; An J; Zheng X; Han D; Chen Z
Biomed Pharmacother; 2022 Sep; 153():113535. PubMed ID: 36076517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]